Medical Condition News

RSS

Speaking more languages may lower risk of developing memory problems

People who speak more than two languages may lower their risk of developing memory problems, according a study released today that will be presented at the American Academy of Neurology's 63rd Annual Meeting in Honolulu April 9 to April 16, 2011.

23 Feb 2011

CAMH introduces mobile research lab to study mental health, addictions in communities across Ontario

Today, the Centre for Addiction and Mental Health launched Canada's first mobile research laboratory to study mental health and addictions in communities across Ontario.

23 Feb 2011

Regeneron submits VEGF Trap-Eye BLA to FDA for treatment of wet AMD

Regeneron Pharmaceuticals, Inc. announced that the company submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration (wet AMD). Under the Prescription Drug User Fee Act (PDUFA), the goal for a standard review time from submission to FDA action is ten months.

22 Feb 2011

Michael & Susan Dell Foundation grants $3.7 million to UTHealth for child obesity prevention, research

To continue their efforts to fight childhood obesity, The Michael & Susan Dell Center for Healthy Living, part of The University of Texas Health Science Center at Houston, has been awarded a four-year grant for $3.7 million grant from the Michael & Susan Dell Foundation.

22 Feb 2011

Study: High-quality hospitals deliver lower-cost care to trauma patients

High-quality hospitals deliver lower-cost care to trauma patients, according to a study published in the Annals of Surgery.

22 Feb 2011

TransPharma completes ViaDor-GLP1 agonist Phase 1b trial for treatment of type II diabetes

TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1b trial of ViaDor-GLP1 agonist, which is being developed for the treatment of diabetes mellitus type II.

22 Feb 2011

Researchers find endothelial dysfunction can predict risk of coronary heart disease

A new study from the Libin Cardiovascular Institute at the University of Calgary's Faculty of Medicine is shedding light on an underlying cause of heart disease.

22 Feb 2011

Infinity commences IPI-926 Phase 2 trial in patients with pancreatic cancer

Infinity Pharmaceuticals, Inc. today announced the initiation of the randomized Phase 2 portion of the trial of IPI-926 in combination with gemcitabine in patients with previously untreated, metastatic, pancreatic cancer.

22 Feb 2011

Health Canada approves Orexo's Abstral to treat chronic cancer pain

Orexo AB today announces that ProStrakan's partner, Paladin Labs Inc. has been informed by Health Canada, the Canadian Government Department with responsibility for public health, that it has approved Abstral.

22 Feb 2011

KemPharm commences KP201 Phase 1 trial for pain

KemPharm, Inc. today announced that it has commenced a Phase 1 clinical trial in healthy volunteers with KP201, its novel abuse deterrent prodrug of hydrocodone for pain. KP201 is a new chemical entity and is the most advanced opioid-based lead candidate in KemPharm's emerging pipeline.

22 Feb 2011

Autism could be detected earlier and easier: Study

Scientists at Boston may have found the beginnings of a non-invasive diagnostic test that can detect abnormal brain waves that suggest increased risk for autism – a debilitating neurological disorder in babies. This test would be safe, inexpensive, and easy to perform and could make it possible for at-risk kids to get help right away rather than having to wait until months or years later, which is now the case with the behavioral tests believe experts.

22 Feb 2011

Healthcare disparities seen in epilepsy patients with low socioeconomic status

A newly published report reveals patients with epilepsy and low socioeconomic status (SES) are more likely to have uncontrolled seizures, drug-related side effects, and a lower overall quality of life. The study also indicates that low SES patients used the hospital emergency room more often and had more visits to a general practitioner than epileptic patients at higher socioeconomic levels. Full findings are now available in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.

22 Feb 2011

New Harris Poll suggests that many doctors dont help obese patients to lose weight

A new Harris Poll suggests that many doctors are doing little or nothing to help their overweight patients to lose weight.

22 Feb 2011

Noninvasive test to evaluate risk of ASD in infants

A computational physicist and a cognitive neuroscientist at Children's Hospital Boston have come up with the beginnings of a noninvasive test to evaluate an infant's autism risk.

22 Feb 2011

Epilepsy patients with low SES more likely to have poor quality of life

A newly published report reveals patients with epilepsy and low socioeconomic status are more likely to have uncontrolled seizures, drug-related side effects, and a lower overall quality of life.

22 Feb 2011

FDA refuses Delcath's chemosaturation delivery system NDA filing

Delcath Systems, Inc. announced today that the Company has received a "refusal to file" letter from the U.S. Food & Drug Administration for the New Drug Application for its proprietary chemosaturation system used in the treatment of patients with metastatic melanoma in the liver through the percutaneous intra-arterial administration of melphalan hydrochloride.

22 Feb 2011

Mutated cancer pathway studies identify therapeutic targets for congenital heart disease

Cross-disciplinary teams of scientists studying genetic pathways that are mutated in many forms of cancer, but which also cause certain forms of congenital heart disease - including hypertrophic cardiomyopathy, a thickening of the heart muscle that is the leading cause of sudden death in children and young adults -, have introduced these mutations into mice and successfully treated HCM in the lab.

22 Feb 2011

Pieris: New interim PRS-050 Phase I data against cancer to be presented at Tri-Conference in California

Pieris AG announced today the upcoming presentation of new preclinical and interim Phase I clinical trial data for its PRS-050 Anticalin(r) program, currently under evaluation for the treatment of cancer.

22 Feb 2011

MedTrust, Avantra collaborate to develop molecular diagnostic assay for cancer care

MedTrust Online and Avantra Biosciences announced today a novel collaboration to involve clinicians in the earliest stages of molecular diagnostic assay development for Avantra Biosciences' revolutionary QPDx multiplex immunoassay system.

22 Feb 2011

Simple on-road tests can help determine safe driving after stroke

Many people want to keep driving after having a stroke, and many can do so safely. Simple tests in the office can help doctors determine who is more likely to be a safe driver after a stroke, according to research published in the February 22, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.

22 Feb 2011

Medical Condition News

Speaking more languages may lower risk of developing memory problems

CAMH introduces mobile research lab to study mental health, addictions in communities across Ontario

Regeneron submits VEGF Trap-Eye BLA to FDA for treatment of wet AMD

Michael & Susan Dell Foundation grants $3.7 million to UTHealth for child obesity prevention, research

Study: High-quality hospitals deliver lower-cost care to trauma patients

TransPharma completes ViaDor-GLP1 agonist Phase 1b trial for treatment of type II diabetes

Researchers find endothelial dysfunction can predict risk of coronary heart disease

Infinity commences IPI-926 Phase 2 trial in patients with pancreatic cancer

Health Canada approves Orexo's Abstral to treat chronic cancer pain

KemPharm commences KP201 Phase 1 trial for pain

Autism could be detected earlier and easier: Study

Healthcare disparities seen in epilepsy patients with low socioeconomic status

New Harris Poll suggests that many doctors dont help obese patients to lose weight

Noninvasive test to evaluate risk of ASD in infants

Epilepsy patients with low SES more likely to have poor quality of life

FDA refuses Delcath's chemosaturation delivery system NDA filing

Mutated cancer pathway studies identify therapeutic targets for congenital heart disease

Pieris: New interim PRS-050 Phase I data against cancer to be presented at Tri-Conference in California

MedTrust, Avantra collaborate to develop molecular diagnostic assay for cancer care

Simple on-road tests can help determine safe driving after stroke

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News